Mark R Kelley

10PUBLICATIONS
32CO-AUTHORS
Haematological tumoursVision scienceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cheminformatics and quantitative structure-activity relationshipsHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 20, 2026
Ref-1 drives ulcerative colitis induced systemic defects in hematopoietic cells.

Ramesh Kumar, Rahul Kanumuri, Sarah S Burns

|Feb 04, 2025
Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1α.

Gabriella D Hartman, Anbukkarasi Muniyandi, Kamakshi Sishtla

|Nov 25, 2023
APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.

Lauren Sahakian, Ainsley M Robinson, Linda Sahakian

|Oct 26, 2023
Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330.

Larissa L Silva, Robert E Stratford, Richard Messmann

|May 04, 2023
Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.

Anbukkarasi Muniyandi, Gabriella D Hartman, Yang Song

|Jan 21, 2023
Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.

Mahmut Mijit, Sheng Liu, Kamakshi Sishtla

Pageof 2